How Does Darzalex Faspro Work for Multiple Myeloma? Darzalex Faspro is a type of medicine called a monoclonal antibody that is also known as a targeted therapy or an immunotherapy. It works by ...

Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control ... diarrhea, mouth ...

How Well Does Talvey Work for Multiple Myeloma? Talvey was studied in people who had relapsed or refractory myeloma. This study included people who had received at least three prior types of ...

CAR T-cell therapy targeting B-cell maturation antigen (BCMA) has become a game changer for patients with relapsed or refractory multiple myeloma. In 2021, the FDA approved idecabtagene vicleucel (ide ...

Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.

Malignant diseases include acute leukemia or multiple myeloma. However, the HCT itself and prophylactic immunosuppressive treatment can play different roles in different conditions.

By MELINDA J. OVERSTREET for Glasgow News 1 In September 2023, he had been fighting a cold for weeks and weeks. His immune ...

We've come a long way since the first immunomodulatory agent was approved for use in myeloma. This review will update you on the latest developments.

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma Results At the data-cutoff date, 232 patients had received talquetamab (102 intravenously and 130 subcutaneously).

In real-world patients with relapsed or refractory multiple myeloma, Carvykti CAR-T cell therapy may be effective. In a real-world setting, standard-of-care Carvykti (ciltacabta-gene autoleucel) has ...

Common side effects associated with high-dose therapy include nausea, vomiting, diarrhea, mouth sores, skin rashes, hair loss, fever, chills, and infection.